Home › Salivary Gland Cancer › NCT04452162
Physiologic MR Imaging of Salivary Gland Tumors
Recruiting
Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Possess a salivary gland lesion of 1cm3 size * Have no prior history of treatment for salivary gland lesion Exclusion Criteria: * Has any prior history of cancer other than SGT * Has any MRI contra-indications * Has a history of known renal disease. * Has history of prior radiation to head and neck region * Is pregnant
About the study
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
What is being tested
- MRI (diagnostic test)
Sponsor: Abramson Cancer Center at Penn Medicine · Participants: 30 · Started: Aug 25, 2020
Contact the study team
- Marisa Sanchez · Phone: 2159019994
- Lisa Desiderio · Phone: 610-721-3365
Official record on ClinicalTrials.gov — NCT04452162
Locations in the U.S.
| Pennsylvania | Hospital of the University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.